Fenglei Li
- Surgery top 10%
- Immunology top 10%
- Epidemiology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Oncology
- Topics
- Esophageal Cancer Research and Treatment (20 papers)Esophageal and GI Pathology (13 papers)Gastric Cancer Management and Outcomes (7 papers)
- Cited by
- HepatologyImmunologyOncology
- Partner nations
- ChinaEthiopiaUnited Kingdom
In The Last Decade
Fenglei Li
46 papers receiving 1000 citations
Peers
Comparison fields: 5 of 95
- Surgery 310
- Immunology 288
- Epidemiology 251
- Pulmonary and Respiratory Medicine 213
- Oncology 205
Countries citing papers authored by Fenglei Li
This map shows the geographic impact of Fenglei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenglei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenglei Li more than expected).
Fields of papers citing papers by Fenglei Li
This network shows the impact of papers produced by Fenglei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenglei Li. The network helps show where Fenglei Li may publish in the future.
Co-authorship network of co-authors of Fenglei Li
This figure shows the co-authorship network connecting the top 25 collaborators of Fenglei Li. A scholar is included among the top collaborators of Fenglei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenglei Li. Fenglei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 16 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 4 | |
| 8 | 21 | |
| 9 | 17 | |
| 10 | 16 | |
| 11 | 66 | |
| 12 | 15 | |
| 13 | 18 | |
| 14 | 14 | |
| 15 | 89 | |
| 16 | 143 | |
| 17 | 75 | |
| 18 | 3 | |
| 19 | 142 | |
| 20 | 7 |
About Fenglei Li
Fenglei Li is a scholar working on Gastroenterology, Surgery and Pulmonary and Respiratory Medicine, having authored 49 papers that have together received 1.0k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (20 papers), Esophageal and GI Pathology (13 papers) and Gastric Cancer Management and Outcomes (7 papers). The work is most often cited by research in Hepatology (121 citations), Immunology (288 citations) and Oncology (205 citations). Fenglei Li has collaborated with scholars based in China, Ethiopia and United Kingdom. Frequent co-authors include Zhigang Tian, Haiming Wei, Rui Sun, Yongyan Chen, Chuanhai Guo, Zhisong He, Yaqi Pan, Hong Cai, Mengfei Liu and Wenwei Yin. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.